User contributions
- 14:44, 22 November 2024 diff hist +7,400 N Boonebowers2086 Created page with "In CM, emerging evidence suggests that neoadjuvant immunotherapy with anti-CTLA-4 plus anti-PD1 is a game changer in patients with palpable nodal Stage III or resectable Stage..." current